Vanina de Verneuil, EVP, General Counsel, Corporate Secretary at Vir Biotechnology, Inc. (VIR), sold 2,385 shares at $5.16 ($12K) on 2025-11-05, disclosed to the SEC on 2025-11-07.
Scheduled sale ($12k) by EVP, General Counsel, Corporate Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VIR | SELL | 2025-11-04 | $8K | — | Filing → |
| VIR | SELL | 2025-02-27 | $135K | — | Filing → |
| VIR | SELL | 2025-02-25 | $49K | — | Filing → |